name: scientific-manuscript
description: "High-impact scientific manuscript preparation for journals like Nature, Blood, Cell. Use when writing abstracts, introductions, methods, results, discussions, or figure legends. Includes citation management, statistical reporting standards, ICMJE guidelines, and journal-specific formatting for hematology/oncology publications."
license: Proprietary
Scientific Manuscript Preparation
Document Structure for High-Impact Journals
Title
- Concise (<15 words for Nature, <20 for Blood)
- Include key finding and system/disease
- Avoid jargon and abbreviations
Abstract (Structured for Blood/Clinical Journals)
**Background:** One sentence on knowledge gap.
**Methods:** Key approaches, patient cohort size, techniques.
**Results:** Primary findings with statistics (P values, CIs).
**Conclusions:** Clinical/translational significance.
Introduction (~500-800 words)
- Paragraph 1: Broad context, disease burden, clinical relevance
- Paragraph 2: Current knowledge, key mechanisms
- Paragraph 3: Knowledge gap, unanswered questions
- Paragraph 4: Study aims, hypothesis, approach overview
Methods (Detailed, Reproducible)
**Patient Cohort and Samples**
- IRB approval number, consent process
- Inclusion/exclusion criteria
- Sample processing, storage conditions
**Single-Cell RNA Sequencing**
- Library preparation (10x Genomics Chromium 3' v3.1)
- Sequencing platform, read depth
- Quality metrics (cells/sample, genes/cell, % mitochondrial)
**Computational Analysis**
- Software versions (Scanpy 1.9.x, scvi-tools 0.20.x)
- QC thresholds (min genes, max %MT)
- Integration method (TotalVI, Harmony)
- Clustering parameters (resolution, n_neighbors)
- Differential expression (Wilcoxon, FDR < 0.05, |log2FC| > 1)
**Statistical Analysis**
- Software (R 4.3.x, Python 3.11)
- Tests used with justification
- Multiple testing correction method
- Power analysis if applicable
Results (~2000-3000 words)
- Lead each paragraph with key finding
- Reference figures in order (Figure 1A-C...)
- Report exact P values (P = 0.003, not P < 0.05)
- Include confidence intervals where relevant
- Avoid interpretation; save for Discussion
Discussion (~1500-2000 words)
**Paragraph 1**: Summarize key findings, relate to hypothesis
**Paragraph 2-4**: Compare to existing literature
- "Consistent with [Author et al.], we found..."
- "In contrast to [Study], our analysis revealed..."
- Mechanistic interpretation
**Paragraph 5**: Translational/Clinical implications
- Therapeutic targets
- Biomarkers
- Patient stratification
**Paragraph 6**: Limitations
- Sample size, cohort characteristics
- Technical limitations
- Generalizability
**Paragraph 7**: Future directions and conclusion
Statistical Reporting Standards
Continuous Variables
- Mean ± SD (normal) or Median [IQR] (non-normal)
- Report normality test used
Categorical Variables
- N (%) with comparison test
P Values
- Report exact values (P = 0.023)
- For very small: P < 0.0001
- Always report test used
Sample Sizes
- "n = X patients" or "n = X cells"
- Report for each comparison group
Figure Legends Template
**Figure 1. Title describes main finding**
(A) Brief description of panel A. Statistical test, P value.
(B) Description including axis labels if not obvious.
(C-D) Can combine similar panels.
Scale bars: X μm. Error bars: mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
n = X biological replicates from Y independent experiments.
Reference Formatting
Blood Journal (Vancouver)
1. Smith JA, Jones BC. Title of article. Blood. 2024;143(5):567-578.
Nature (Author-Year)
Smith, J.A. & Jones, B.C. Title of article. Nature 620, 567–578 (2024).
Journal-Specific Requirements
Blood (ASH)
- Word limit: 4000 (full article)
- Figures: 7 max
- References: 60 max
- Structured abstract: 250 words
Nature
- Word limit: ~3000 (Article)
- Main text figures: 6-8
- Methods: no limit, separate section
- Extended Data for supplementary figures
Cell
- Word limit: 7000 (Article)
- STAR Methods format
- Graphical abstract required
HIPAA Compliance Reminders
- No patient identifiers in any form
- Use Specimen IDs, not patient names/MRNs
- Aggregate data for small groups (n < 5)
- IRB approval statement required
- Data availability statement (GEO accession for sequencing)
Writing Style
- Active voice preferred
- Past tense for results ("We found...")
- Present tense for established facts
- Avoid "interesting," "significant" (unless statistical)
- Be specific: "83.9-fold increase" not "marked increase"
See references/journal_templates.md for specific formats.
See references/statistical_tests.md for test selection guide.
1---2name: scientific-manuscript3description: COPYRIGHT NOTICE4---5
6<!--
7# COPYRIGHT NOTICE
8# This file is part of the "Universal Biomedical Skills" project.
9# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>
10# All Rights Reserved.
11#
12# This code is proprietary and confidential.
13# Unauthorized copying of this file, via any medium is strictly prohibited.
14#
15# Provenance: Authenticated by MD BABU MIA
16
17-->
18
19---
20name: scientific-manuscript
21description: "High-impact scientific manuscript preparation for journals like Nature, Blood, Cell. Use when writing abstracts, introductions, methods, results, discussions, or figure legends. Includes citation management, statistical reporting standards, ICMJE guidelines, and journal-specific formatting for hematology/oncology publications."
22license: Proprietary
23---
24
25# Scientific Manuscript Preparation
26
27## Document Structure for High-Impact Journals
28
29### Title
30- Concise (<15 words for Nature, <20 for Blood)
31- Include key finding and system/disease
32- Avoid jargon and abbreviations
33
34### Abstract (Structured for Blood/Clinical Journals)
35
36```markdown
37**Background:** One sentence on knowledge gap.
38**Methods:** Key approaches, patient cohort size, techniques.
39**Results:** Primary findings with statistics (P values, CIs).
40**Conclusions:** Clinical/translational significance.
41```
42
43### Introduction (~500-800 words)
441. **Paragraph 1**: Broad context, disease burden, clinical relevance
452. **Paragraph 2**: Current knowledge, key mechanisms
463. **Paragraph 3**: Knowledge gap, unanswered questions
474. **Paragraph 4**: Study aims, hypothesis, approach overview
48
49### Methods (Detailed, Reproducible)
50
51```markdown
52**Patient Cohort and Samples**
53- IRB approval number, consent process
54- Inclusion/exclusion criteria
55- Sample processing, storage conditions
56
57**Single-Cell RNA Sequencing**
58- Library preparation (10x Genomics Chromium 3' v3.1)
59- Sequencing platform, read depth
60- Quality metrics (cells/sample, genes/cell, % mitochondrial)
61
62**Computational Analysis**
63- Software versions (Scanpy 1.9.x, scvi-tools 0.20.x)
64- QC thresholds (min genes, max %MT)
65- Integration method (TotalVI, Harmony)
66- Clustering parameters (resolution, n_neighbors)
67- Differential expression (Wilcoxon, FDR < 0.05, |log2FC| > 1)
68
69**Statistical Analysis**
70- Software (R 4.3.x, Python 3.11)
71- Tests used with justification
72- Multiple testing correction method
73- Power analysis if applicable
74```
75
76### Results (~2000-3000 words)
77- Lead each paragraph with key finding
78- Reference figures in order (Figure 1A-C...)
79- Report exact P values (P = 0.003, not P < 0.05)
80- Include confidence intervals where relevant
81- Avoid interpretation; save for Discussion
82
83### Discussion (~1500-2000 words)
84
85```markdown
86**Paragraph 1**: Summarize key findings, relate to hypothesis
87
88**Paragraph 2-4**: Compare to existing literature
89- "Consistent with [Author et al.], we found..."
90- "In contrast to [Study], our analysis revealed..."
91- Mechanistic interpretation
92
93**Paragraph 5**: Translational/Clinical implications
94- Therapeutic targets
95- Biomarkers
96- Patient stratification
97
98**Paragraph 6**: Limitations
99- Sample size, cohort characteristics
100- Technical limitations
101- Generalizability
102
103**Paragraph 7**: Future directions and conclusion
104```
105
106## Statistical Reporting Standards
107
108### Continuous Variables
109- Mean ± SD (normal) or Median [IQR] (non-normal)
110- Report normality test used
111
112### Categorical Variables
113- N (%) with comparison test
114
115### P Values
116- Report exact values (P = 0.023)
117- For very small: P < 0.0001
118- Always report test used
119
120### Sample Sizes
121- "n = X patients" or "n = X cells"
122- Report for each comparison group
123
124## Figure Legends Template
125
126```markdown
127**Figure 1. Title describes main finding**
128(A) Brief description of panel A. Statistical test, P value.
129(B) Description including axis labels if not obvious.
130(C-D) Can combine similar panels.
131Scale bars: X μm. Error bars: mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001.
132n = X biological replicates from Y independent experiments.
133```
134
135## Reference Formatting
136
137### Blood Journal (Vancouver)
138```
1391. Smith JA, Jones BC. Title of article. Blood. 2024;143(5):567-578.
140```
141
142### Nature (Author-Year)
143```
144Smith, J.A. & Jones, B.C. Title of article. Nature 620, 567–578 (2024).
145```
146
147## Journal-Specific Requirements
148
149### Blood (ASH)
150- Word limit: 4000 (full article)
151- Figures: 7 max
152- References: 60 max
153- Structured abstract: 250 words
154
155### Nature
156- Word limit: ~3000 (Article)
157- Main text figures: 6-8
158- Methods: no limit, separate section
159- Extended Data for supplementary figures
160
161### Cell
162- Word limit: 7000 (Article)
163- STAR Methods format
164- Graphical abstract required
165
166## HIPAA Compliance Reminders
167
168- No patient identifiers in any form
169- Use Specimen IDs, not patient names/MRNs
170- Aggregate data for small groups (n < 5)
171- IRB approval statement required
172- Data availability statement (GEO accession for sequencing)
173
174## Writing Style
175
176- Active voice preferred
177- Past tense for results ("We found...")
178- Present tense for established facts
179- Avoid "interesting," "significant" (unless statistical)
180- Be specific: "83.9-fold increase" not "marked increase"
181
182See `references/journal_templates.md` for specific formats.
183See `references/statistical_tests.md` for test selection guide.
184
185
186<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->